跳至主要内容
临床试验/NCT03528811
NCT03528811Unknown1 期

Evaluation of Microcirculation of Peripheral Vascular Disease in Diabetes

Shanghai 10th People's Hospital1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2016年8月1日最近更新:
适应症
干预措施

试验速览

阶段
1 期
发起方
入组人数
300
试验地点
1
主要终点
Coincidence rate of "5 points test of Tongji university"

研究概览

简要总结

The main aim of the present study was to evaluate the microcirculation of peripheral vascular disease in diabetes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 1.Patients with Peripheral vascular disease with or without diabetes. 2.Rutherford class 2-
  • 3.Target lesions with a diameter reduction of at least 50% on angiography, and without past history of any intervention.
  • 4.Target vessel with 2.0--10.0mm in diameter and having a lesion of about 4cm-20cm in length.
  • 5.Written informed consent signed by the patients or representatives

排除标准

  • 1.Previous bypass surgery or stent placement at the ipsilateral lower limb 2.History of intolerance to antiplatelet therapy, heparin, or contrast media. 3.Bleeding diathesis; 4.Active systemic bacterial infection; 5.Severely impaired renal function (serum creatinine level > 2.5 mg/dL. Expected survival time of less than 24 months

研究组 & 干预措施

Five points test of Tongji university

Other

We established the evaluatation and follow-up system of diabetes vascular disease based on the method called "Five points test of Tongji university" .

干预措施: Five points test of Tongji university (Diagnostic Test)

结局指标

主要结局

Coincidence rate of "5 points test of Tongji university"

时间窗: 12 months

The primary study endpoint was that the coincidence rate of evaluating the microcirculation by the newly-established "5 points test of Tongji university" attains over 95% before and after operations as assessed by digital substraction angiography (DSA).

次要结局

未报告次要终点

研究者

发起方
Shanghai 10th People's Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Maoquan Li

Chief Physician

Shanghai 10th People's Hospital

研究点 (1)

Loading locations...

相似试验